Credit Corp: Capital strength
About the author:
- Author name:
- By Scott Murdoch
- Job title:
- Senior Analyst
- Date posted:
- 02 February 2022, 10:00 AM
- Sectors Covered:
- Diversified Financials, Professional Services
- Credit Corp (ASX:CCP) delivered 1H22 underlying NPAT of A$45.7m, up 8% on pcp. Strong lending volumes (upfront provisioning) slightly dragged on the result vs expectations.
- FY22 NPAT guidance was reaffirmed at A$92-97m, with PDL buying guidance increased ~7% (to A$300-320m).
- AUS/NZ PDL supply remains subdued, with slight improvement commencing (short-term assisted by inventory transactions like Radio Rentals). Strength in the USA pipeline (~A$155m contracted) is positive for FY23/24 growth.
- CCP’s balance sheet (slight net cash; ~A$313m debt capacity) provides optionality.
- CCP’s valuation is reasonably full (~21x FY23F PE), however we see upside earnings risk from further capital deployment (primarily acquisitions) over a 12-18 month period and retain our positive view on this basis. Add maintained.
Event: Solid 1H22 result
Credit Corp (ASX:CCP) reported 1H22 NPAT of A$45.7m, up 8% on the pcp and ~4% below our expectations. The slight ‘miss’ versus our forecast resulted from higher upfront loan provisioning (accelerated volumes over Nov/Dec).
We had expected CCP to utilise some of the provisioning strength, however the consumer loan book remains conservatively provisioned at ~26.7% (vs ~18.7% pre-Covid levels).
Reported NPAT (A$50.2m) benefitted from a US Paycheck Protection Program loan forgiveness (A$4.5m). Interim dividend 38cps (+5.6%). Net cash of A$1.1m.
Divisional NPAT composition included (on pcp): AUS debt buying +5% to A$29m; USA debt buying +31% to A$10.5m; Lending down 7% to A$6.2m.
PDL cash collections increased +8.8% to ~A$272m, which was driven by AUS/NZ collections up ~6% to A$191m (including a part contribution from Radio Rentals) and the USA up ~15% to A$81m.
The gross Lending book closed at A$200m, +16% for the qtr and +8% for the half.
Analysis: AUS core PDL buying remains difficult; USA accelerating
FY22 guidance includes: NPAT A$92-97m; PDL acquisitions A$300-320m (increased by A$20m); and net lending A$45-55m. The PDL contracted pipeline stands at A$293m (~A$155m USA; ~A$60m RR; ~A$78m AUS core).
The USA division remains on track for an earnings step up, with CCP’s intention to move to and sustain ~A$200m purchasing. USA collections accelerated over the half (1Q A$37m; 2Q A$44m) on the back of improved purchasing. Operational capacity remains the current constraint, with headcount growth to 600 (from 374) required.
PDL purchasing guidance implies ~A$100m of AUS core buying, still significantly below the required levels to maintain AUS profitability (~A$160m). The addition of Radio Rental will assist 2H22/FY23, however volumes will need to build through CY22 to prevent a headwind to AUS divisional profitability.
Consumer Lending experienced a strong volume recovery in Nov/Dec (up ~25% on pre-Covid-19 volumes), resulting in book growth to A$200m (+16% for the qtr). CCP expect the division to deliver ~A$12m 2H22 NPAT (from A$6.2m in 1H22).
Forecast and valuation update
Minor changes to forecasts. Our forecasts sit slightly ahead of guidance. (login to view price target)
Add maintained. We view CCP as having a visible medium-term growth profile: we expect AUS PDL supply to improve over FY23 (with the potential for larger transactions / an acquisition to assist); we expect CCP to capitalise on the market share opportunity in the USA; and a rebound in consumer lending.
Whilst CCP’s near-term valuation is fair, CCP’s balance sheet position provides optionality and medium-term upside earnings risk.
- Capital deployment via large inventory purchase; USA PDLs or acquisitions.
- Lower than expected PDL supply/competitive pressure;
- Structural industry change impacting supply;
- Reputational risks;
- Regulatory risks.
Find out more
Download full research note
You can find further detailed analysis of company results this reporting season by browsing our reporting season tag, and view a full list of upcoming results on our Reporting Season Calendar.
If you would like access or more information, please contact your adviser or nearest Morgans office.
Request a call
Find local branch
Need access to our research?
You are also welcome to start a two-week trial of our online platform, which provides access to detailed market analysis and insights, provided by our award-winning research team.
Create trial account
Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.